Urologic_sarcoma_in_adults._Memorial_Sloan-Kettering_Cancer_Center_experience_based_on_a_prospective_database_between_1982_and_1989._Urologic_sarcoma_is_a_group_of_rare_tumors_with_a_generally_poor_prognosis._These_sarcomas_share_prognostic_characteristics_with_soft-tissue_sarcomas_arising_from_other_sites._A_staging_system_that_incorporates_tumor_grade_and_size_is_valuable_in_identifying_patients_at_high_risk_of_dying_of_disease._Patients_with_sarcomas_that_are_high-grade,_greater_than_5_cm_in_diameter,_or_metastatic_at_the_time_of_presentation_(MSKCC_stages_3_and_4)_have_a_combined_3-year_relapse-free_survival_rate_of_26%._Complete_surgical_resection,_preferably_with_negative_margins,_still_offers_the_best_chance_of_cure._For_reasons_that_are_not_clear,_multimodality_therapy_in_rhabdomyosarcoma_is_less_effective_in_adult_than_in_pediatric_disease._Present-day_chemotherapeutic_regimens_are_ineffective_in_controlling_disseminated_sarcoma._The_adoption_of_a_uniform_staging_system_coupled_with_multi-institutional_collaboration_may_allow_progress_to_be_made_in_this_otherwise_deadly_form_of_genitourinary_cancer.